Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155256 | SCV000204942 | uncertain significance | not specified | 2014-07-01 | criteria provided, single submitter | clinical testing | The Pro1111Leu variant in OTOF has not been previously reported in individuals w ith hearing loss, but has been identified in 0.14% (6/4406) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/ EVS/; dbSNP rs141972928). Computational prediction tools and conservation analys is suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, additional informa tion is needed to fully assess the clinical significance of this variant. |
Otorhinolaryngology Lab - |
RCV001729416 | SCV001792224 | pathogenic | Autosomal recessive nonsyndromic hearing loss 9 | criteria provided, single submitter | research | in compound heterozygosis with the c.2153G>A variant ina subject with bilateral non-syndromic prelingual auditory neuropathy (sporadic) | |
Labcorp Genetics |
RCV002514990 | SCV003267731 | likely benign | not provided | 2024-12-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002514990 | SCV005331613 | uncertain significance | not provided | 2024-01-09 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34599368) |